Objective: To determine clinical, radiological, and laboratory findings as well as mortality rates in younger and older patients with pulmonary embolism (PE) and investigate risk factors associated with mortality in elderly patients.
INTRODUCTION
Pulmonary embolism (PE) is a major health problem in elderly patients associated with significant morbidity and mortality. While the incidence of pulmonary embolism in general population is 0.5-1/1000 (1), it increases with aging and reaches as high as 4/1000 in patients older than 70 years of age (2). The age-related increase in frequencies of deep vein thrombosis and PE may result from some changes observed in aging individuals including increment of fibrinogen, reduction of antithrombin-3, reduction of muscle mass in the extremities and venous stasis because of immobility(3).
The presence of accompanying co-morbidities and confusion of symptoms and signs of PE with those of co-morbidities in geriatric population lead to delays in diagnosis and treatment of PE (4). Furthermore, because of reduced cardio-pulmonary reserve in elderly patients, the ventilation/perfusion balance deteriorates more markedly after embolism compared to younger patients and emerging right heart failure results in mortality (5). The determination of risk factors associated with mortality in elderly PE patients may contribute to proper management of these cases. Although there are some previous reports evaluating such risk factors in various PE populations (6-10), small number of them have evaluated geriatric population (7-10). Moreover, studies comparing geriatric and non-geriatric patients are sparse (9, 10).
In the current study, we aimed to determine clinical, radiological, and laboratory findings as well as mortality rates in older patients with PE and to compare them with younger patients in terms of those findings. It was also aimed to investigate the risk factors associated with mortality and their predictive values in elderly PE patients.
MATERIALS AND METHODS

The characteristics of patients
In this study, we have retrospectively evaluated the patients hospitalized with acute PE in Pulmonology Clinic of Dicle University Faculty of Medicine, between January 2010 and December 2014. Patients under 18 years of age and with inadequate clinical information were excluded from the study. The study was approved by local ethics committee.
Study design
The demographic and clinical characteristics of patients, co-morbid diseases, presence of deep vein thrombosis, recent operations, and other risk factors for PE and laboratory findings including complete blood count, blood biochemical parameters, arterial blood gas analysis, markers of hypercoagulable state, and the treatment applied were denoted from electronic database of the hospital and medical records of the patients. The blood samples had been obtained within 24 hours of admission. Computerized tomography pulmonary angiography and transthoracic echocardiography results were also recorded. All-cause mortality status within 90 days following PE diagnosis was searched and recorded for every patient using computerized database.
The severity of PE was assessed according to simplified pulmonary embolism severity index (sPESI) value which was calculated for every patient. For calculation of sPESI, one point was given for the presence of each of the following: age >80 years, history of cancer, history of chronic cardiopulmonary disease, heart rate ≥110 beats/min, systolic blood pressure <100 mmHg, and an arterial oxygen saturation <90% at the time of PE diagnosis and accordingly, the patients were classified into low-risk (0 point) or high-risk (≥1 point) categories (11) . Massive PE was diagnosed according to the Guidelines on the Diagnosis And Management of Acute Pulmonary Embolism of the European Society of Cardiology(1) .
The cases over 65 years of age were categorized into "older" group, while the remainder constituted the "younger" group. Then, the clinical and laboratory findings of these two groups were compared.
The transthoracic echocardiographic evaluation
All echocardiographic examinations were performed in accordance with the recommendations of the American Society for Echocardiography (11) . A Vivid 7 Pro ultrasound system (GE Medical Systems, Vingmed Ultrasound AS, Norway) was used with appropriate transducers to carry out echocardiographic studies. Left and right ventricular as well as left and right atrial diameters, left ventricular shortening and ejection fractions, and pulmonary artery systolic pressure were measured and recorded. The patients with a pulmonary artery systolic pressure greater than 40 mmHg was accepted to have pulmonary hypertension (12) .
Evaluation of computerized tomography (ct) pulmonary angiography
Every patients underwent CT pulmonary angiography on a 64 slice multi detector CT scanner (Brilliance CT scanner, Philips Healthcare, Netherlands). The scanning was performed by application of 64×0.625 mm collimation, 1mm slice thickness, 0.5 mm reconstruction increment, and 0.5-second rotation time. One hundred milliliters of a nonionic contrast medium was applied by an automatic injector (CT Injector Missouri, Ulrich Medical, Germany) at a flow rate of 5 mL/s, followed by 30-40 mL NaCl bolus via an antecubital vein.
The diagnosis of PE was established by visualization of non-occlusive endoluminal thrombus or complete occlusion of pulmonary artery and/or its branches by thrombus (13) .
The statistical analysis
Data analysis was performed using a statistical software package ( Qualitative variables were compared by chi-square test. Parameters with significant differences were further evaluated with binary logistic regression analysis to determine independent risk factors for 90-day-mortality. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. Variables with a p value less than 0.05 in univariate analysis were included in multivariate model.
RESULTS
Total number of PE patients were 253. One hundred and fifty-four of them (60.9%) were female and the remainder 99 (39.1%) were male (female/male: 1.6). One hundred five (41.5%) were older, while 148 (58.5%) were younger patients. The mean age of older and younger cases were 75.5 ± 6.4 and 45.2 ± 12.8 years, respectively. Comparison of these groups revealed more frequent presence of co-morbidities and higher sPESI scores in older group. (Table 1 ). The 90-day mortality rate of older patients was higher than younger patients patients (76.7%) and they showed that the frequency of thrombi of proximal pulmonary arterial branches (main and/or lobar pulmonary arteries) was higher in elderly than in younger cases (p = 0.042).
Increased sPESI, c-reactive protein (CRP), BUN, and creatinine levels; decreased albumin level, neutrophil-to-lymphocyte ratio, and leukocyte count as well as the presence of cough, dyspnea, pulmonary infarction, co-morbiditiy, history of immobility, malignancy, trauma, and operation were found to increase 90-day-mortality (All p values < 0.05).
However, multivariate analysis revealed that a sPESI equal or higher than 1 (p = 0. (Table 3 ). Higher D-dimer levels were not found to increase mortality risk in none of the groups.
DISCUSSION
In the current study, it was determined that the mortality rate, systolic pulmonary artery pressure, the frequency of hypoxemia, and D-dimer levels were higher in elderly patients with PE compared to younger patients. Increased BUN and CRP levels, an sPESI ≥1, accompanying co-morbidities, and undergoing surgery were independent risk factors associated with increased mortality in elderly patients.
The elderly population are at increased risk for pulmonary embolism owing to both the conditions common to this age group, and the immobility which frequently accompanies them. Both reduced cardio-pulmonary reserves and increased probability of co-morbidities increase the risk of mortality in elderly patients (4). Additionally, confusion of the symptoms of cardiovascular and pulmonary diseases with the ones of PE as well as decreased ability of sensation and distinction may delay the diagnosis of PE and increase the mortality rate in elderly people(5).
PESI is one of the most widely validated prognostic model for 30-day-mortality (11).
The number of parameters evaluated in simplified PESI is less than PESI and therefore it is less complicated (14) . Kılıç et al. (15) showed that sPESI was an effective prognostic model to predict short-and long-term mortality PE patients regardless of age. In some other studies, the frequencies of 90-day-mortality were found 25 to 54% in elderly PE patients with a sPESI score indicating high risk (7, 16). In accordance with these investigations, we determined 90-day-mortality as high as 55% in elderly patients with a sPESI equal or greater than one.
Having a sPESI ≥1 was found associated with five-fold increase in 90-day-mortality rate in our elderly group, compared to the cases with an index lower than one. Given that one of the parameters scored in calculation of sPESI is being older than 80 years old and 20 (19%) of cases in our elderly group were older than 80 years, this finding may not be surprising.
Consistently, there was no correlation between the sPESI and 90-day-mortality in younger patients. However, as most of our elderly group are below 80 years old, some risk factors other than age may also affect mortality risk. Higher sPESI indicating increased mortality risk in elderly PE patients should make clinicians take proper measures to decrease mortality.
Co-morbidities develop with aging and those increase mortality rates in elderly people. PE results in increased frequencies of hemodynamic instability and mortality in these patients, especially, in the ones with cardiopulmonary diseases(5). A study evaluating annual mortality rates in patients with chronic obstructive pulmonary disease (COPD) have found that accompanying PE increased the mortality rate from 15% to 53.3% (17) . Another study have shown raised mortality rate due to PE in cases with COPD or heart failure (18) . Several other studies also reported similar increase in mortality rates in PE patients owing to various co-morbidities (19, 20) . In consistence with previous reports, we have found that comorbidities caused increased mortality rate in elderly group and among them, this risk was more pronounced for cardiopulmonary diseases. Therefore, clinical suspicion of PE in elderly patients with cardiopulmonary diseases should prompt us to diagnose and start proper treatment in order to reduce possible mortality risk.
Having surgery increases the risk of mortality in elderly patients. Immobilization, venous stasis, and endothelial damage are the major causes of deep vein thrombosis in elderly patients undergoing surgery (21, 22) . It has been shown that subclinical pulmonary embolism can be seen in 40-50% of elderly patients with deep vein thrombosis and it increases the risk of mortality (23). Hamel et al. (24) reported that PE was responsible for 47% of postoperative deaths in elderly patients. Parallel with those, mortality risk was found to be increased in our elderly PE cases being operated on within a few weeks. This finding may indicate the importance of preoperative embolism prophylaxis and necessity of careful perioperative management in elderly population.
Besides a physiological decline in renal function with aging, some co-morbid conditions such as hypertension, diabetes, and acute PE may cause renal damage in elderly people (25) . Sudden increase in pulmonary artery pressure resulted from PE may cause right ventricular dysfunction and decreased cardiac output. Consequent decrement in renal blood flow results in renal dysfunction (26) . Increased BUN level is an indicator of renal dysfunction. Increased BUN levels was found related with poor prognosis in liver disease and heart failure (27) . One study identified a relationship indepent from creatinine levels between high BUN levels and mortality in 26,288 patients (28) . Interestingly, we have determined that higher levels of BUN predicted increased mortality risk in both younger and elderly patients with PE. Given that heart failure was present in two of the younger and three of the older patients, it was thought that such increase in mortality risk did not result from heart failure accompanying to renal dysfunction. This is a novel finding in that our search did not reveal any study evaluating BUN in prediction of mortality in PE patients and this finding may indicate the importance of appropriate therapy and careful management of such PE patients in order to reduce the risk of mortality.
Recent studies have proposed that inflammatory markers and acute phase reactants may be involved in pathogenesis of venous thromboembolism and have some prognostic significance (29, 30) . C-reactive protein was found beneficial both in diagnosis of PE and in identification of patients with higher mortality risk within first year of disease (30) . CRP is reported to be associated with worse clinical outcomes and proposed as a predictor of poor prognosis in PE cases in another study (31) . In our study, higher CRP levels has predicted increased 90-day-mortality in elderly patients, but not in younger counterparts. C-reactive protein can be a useful and easily available biochemical marker in determination of mortality risk of PE patients.
Studies evaluating the relationship between D-dimer levels and mortality risk have found contradictory results. While some studies determined increased mortality risk in PE cases with higher D-dimer levels (4, 32) , the others did not find such a relationship (33). We did not determine any relationship between D-dimer levels and mortality risk as well.
Our study have some limitations. Since the data were retrospectively collected, one must be careful in drawing conclusions. The results of this study should be further validated by prospective randomized trials. Transthoracic echocardiography is only performed in those with more severe PE and higher probability of right ventricular dysfunction. Finally, we did not exclude patients with preexisting diseases which may also cause right ventricular enlargement (e.g. COPD).
In conclusion, the current study found quite high mortality rate in elderly pulmonary embolism patients. Higher sPESI, presence of co-morbidities and surgical procedures as well as high BUN and CRP levels are associated with increased mortality risk especially in elderly PE cases. The use of those parameters in prediction of the patients at high mortality risk may drive us to take necessary measures in order to reduce the risk of mortality. 
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